News and features

Gene testing could identify the causes of cancer for up to a quarter of patients with bowel cancer who have a family history of the disease, a new study reports.

It’s been a very busy year here at the ICR. Here are the ten ICR news stories that have proved most popular with readers over the past 12 months.

Here we take a look back at the most read posts on the ICR’s blogs this year. From how personalised medicine could change the world to the babies who cure themselves of cancer – these are the stories that have most grabbed your attention in 2014.

This year's donations income smashes last year’s achievement by more than £3 million.

The European Medicines Agency has approved olaparib for women with ovarian cancer who have a BRCA1 or BRCA2 mutation.

Researchers have discovered the unique genetic paths that the childhood brain tumour medulloblastoma follows when the disease comes back.

Mayor of London Boris Johnson hailed the ICR as a ‘creative powerhouse’, after it was ranked top in the Government’s Research Excellence Framework.

Mayor of London Boris Johnson visited the ICR today to hear about plans to create one of the world’s top centres for cancer drug discovery and life sciences.

The ICR is the top higher education institution in the country in the overall league table of academic performance, the Government’s Research Excellence Framework has revealed.

ICR researchers have used 3D printing to produce replica models of tumours and organs of patients with cancer, to help calculate precisely how much radiation has been delivered to the cancer.

Using two targeted drugs at once could be an effective treatment strategy for children with an aggressive form of cancer who develop resistance to a single targeted drug, a new study shows.

Initial results from a major phase III clinical trial reveal that women with a type of breast cancer are much more likely to respond to chemotherapy drug carboplatin than standard treatment.